Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC lowered its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 79.8% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 10,769 shares of the company’s stock after selling 42,640 shares during the period. Cubist Systematic Strategies LLC’s holdings in Phibro Animal Health were worth $181,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of PAHC. CWM LLC raised its stake in shares of Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after buying an additional 1,035 shares during the last quarter. Fidelis Capital Partners LLC purchased a new position in shares of Phibro Animal Health during the 1st quarter valued at about $46,000. China Universal Asset Management Co. Ltd. raised its stake in shares of Phibro Animal Health by 65.0% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after buying an additional 1,531 shares during the last quarter. Summit Securities Group LLC purchased a new position in shares of Phibro Animal Health during the 2nd quarter valued at about $83,000. Finally, Illinois Municipal Retirement Fund raised its stake in shares of Phibro Animal Health by 7.2% during the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after buying an additional 765 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Bank of America lifted their price target on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. JPMorgan Chase & Co. assumed coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target for the company. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, Phibro Animal Health presently has an average rating of “Hold” and a consensus target price of $15.00.

Insider Buying and Selling

In related news, Director E Thomas Corcoran bought 5,000 shares of the stock in a transaction dated Wednesday, September 4th. The shares were acquired at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the acquisition, the director now directly owns 25,000 shares in the company, valued at approximately $500,500. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 50.06% of the stock is currently owned by insiders.

Phibro Animal Health Trading Up 3.4 %

PAHC stock opened at $24.29 on Tuesday. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. Phibro Animal Health Co. has a 12-month low of $9.40 and a 12-month high of $24.38. The stock has a market cap of $983.82 million, a price-to-earnings ratio of 75.91, a PEG ratio of 0.55 and a beta of 0.52. The business’s 50-day moving average is $20.57 and its 200 day moving average is $18.01.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. The company had revenue of $273.16 million for the quarter, compared to analysts’ expectations of $262.44 million. On average, sell-side analysts anticipate that Phibro Animal Health Co. will post 1.55 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.98%. The ex-dividend date of this dividend was Wednesday, September 4th. Phibro Animal Health’s payout ratio is 150.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.